The content on this site is intended for healthcare professionals only
Prof Hugo Fernandez speaks to ecancer at BEST OF ASCO® 2018 MIAMI SYMPOSIUM about the treatment of myelodysplastic syndromes.
He discusses the various abnormalities and treatments for them, while touching upon recommendations for transplantation.
ASCO GU 2026: Updates in renal cancer
Isatuximab with VRd can benefit newly diagnosed multiple myeloma transplant ineligible patients
Understanding the remaining unmet needs in a post ASCT NDMM setting
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Advancements in paediatric Acute lymphoblastic leukemia management
Multiple myeloma In Rwanda: The need for further research
ASCO 2024: Lung cancer highlights
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
